ACTIVE ANKYLOSING SPONDYLITIS
Clinical trials for ACTIVE ANKYLOSING SPONDYLITIS explained in plain language.
Never miss a new study
Get alerted when new ACTIVE ANKYLOSING SPONDYLITIS trials appear
Sign up with your email to follow new studies for ACTIVE ANKYLOSING SPONDYLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Arthritis drug xeljanz XR under Real-World watch in korea
Disease control Recruiting nowThis study tracks the safety and effectiveness of the arthritis drug Xeljanz XR in about 200 adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis. Participants take the drug as prescribed by their doctor, and researchers record any s…
Matched conditions: ACTIVE ANKYLOSING SPONDYLITIS
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New pill could ease stiffness and pain for ankylosing spondylitis patients
Disease control Recruiting nowThis phase 3 trial tests whether VC005 tablets can reduce symptoms of active ankylosing spondylitis, a type of arthritis that mainly affects the spine. About 420 adults aged 18 to 70 will receive either VC005 or a placebo for 48 weeks. The main goal is to see how many achieve a 2…
Matched conditions: ACTIVE ANKYLOSING SPONDYLITIS
Phase: PHASE3 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC